- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- March 2024
- 397 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- October 2023
- 88 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Perphenazine is a drug used to treat mental disorders such as schizophrenia, bipolar disorder, and severe depression. It is a phenothiazine antipsychotic medication that works by blocking dopamine receptors in the brain, which helps to reduce psychotic symptoms. It is usually taken orally in tablet form, but can also be administered as an injection. Common side effects include drowsiness, dry mouth, blurred vision, and constipation.
Perphenazine is a widely used drug in the mental disorders drugs market. It is often prescribed as a first-line treatment for schizophrenia and bipolar disorder, and is also used to treat severe depression. It is generally well-tolerated and has a low risk of serious side effects.
Some companies in the Perphenazine market include Pfizer, Novartis, and Mylan. Show Less Read more